Cambridge Investment Research Advisors, Inc. Eyenovia, Inc. Transaction History
Cambridge Investment Research Advisors, Inc.
- $29.4 Billion
- Q3 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Eyenovia, Inc. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 14,405 shares of EYEN stock, worth $1,152. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,405
Previous 14,405
-0.0%
Holding current value
$1,152
Previous $9,000
22.22%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding EYEN
# of Institutions
54Shares Held
13.4MCall Options Held
13.1KPut Options Held
21.3K-
Armistice Capital, LLC New York, NY8.53MShares$682,7470.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$150,5030.0% of portfolio
-
Geode Capital Management, LLC Boston, MA558KShares$44,6390.0% of portfolio
-
Lasry Marc New York, NY548KShares$43,8240.74% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny388KShares$31,0490.0% of portfolio
About EYENOVIA, INC.
- Ticker EYEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,212,900
- Market Cap $2.74M
- Description
- Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the develop...